placeholder newsslider

The European Vision Institute EEIG

European Alliance for the Promotion of Vision Research and Ophthalmology

Blindness is one of the most feared health hazards in our present society; millions of Europeans are threatened by blinding untreatable eye diseases producing costs of several billion Euros. EVI aims at devising and implementing programs and projects for new therapeutic strategies for eye diseases that are difficult or impossible to be treated presently. Its approach will incorporate the most recent scientific developments of the postgenomic area.

The Importance of EVI

The European Vision Institute should be of enormous strategic importance for the future and is targeted towards more immediate policy objectives of improving the competitiveness of European Research assembling the top institutes together with partners from industry and academia. EVI integrates, conducts and supports research that helps to prevent and treat eye diseases and other disorders of vision. This research leads to sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life for people of all ages.

Vision Research in Europe

ARVO2020 cancelled because of Coronavirus (COVID-19)

ARVO has decided to cancel the Annual Meeting to have taken place May 1 – 7 in Baltimore, Md, USA Read more

New Technologies for Outcome Measures in Uveal Melanoma

Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology Read more

Eye care is key when you're working from home

If you're one of the many people who've switched to working at home during the COVID-19 pandemic, you need to take care of your eyes, the American Academy of Ophthalmology says. Read more

Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy

Ocuphire Pharma announced that it has screened the first patient in ZETA-1, a phase 2 trial to evaluate APX3330 in non-proliferative diabetic retinopathy (NPDR) and mild proliferative diabetic retinopathy (PDR). Effects on diabetic macular edema will be explored as a secondary outcome. A number of... Read more

Biden wants $6.5 billion for new health agency to speed treatments

The Biden administration began to flesh out a proposal for a new agency—modeled on the military’s Defense Advanced Research Projects Agency (DARPA)—that would seek to speed the development of medical treatments by funding risky, innovative projects. The agency, dubbed ARPA-Health (ARPA-H), would be... Read more

vision-research.eu

The "Gateway to European Vision Research" is a web-based portal service for the European vision research community and major stakeholders.

The Vision Awards

An award and public recognition by any measure is a sign of inimitability - an acknowledgment that peers and professionals alike agree that a certain person excels in what they do.

Read more about the European Vision Award and the Carl Zeiss Young Investigator Award.

Ophthalmic Research

Ophthalmic Research - The Journal for Translational and Clinical Research is official affiliated with the European Vision Institute